Abstract P5-20-07: A phase Ib dose-finding study of subcutaneous pertuzumab in combination with subcutaneous trastuzumab in healthy male volunteers and female patients with early breast cancer

2018 ◽  
Author(s):  
WP Kirschbrown ◽  
C Wynne ◽  
M Kagedal ◽  
R Wada ◽  
H Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Early Breast Cancer ◽  
Dose Finding ◽  
Healthy Male ◽  
Phase Ib ◽  
Female Patients ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Finding Study ◽  
Dose Finding Study

scholarly journals Development of a Subcutaneous Fixed‐Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose‐Finding Study

2018 ◽  
Vol 59 (5) ◽  
pp. 702-716 ◽  
Author(s):  
Whitney P. Kirschbrown ◽  
Chris Wynne ◽  
Matts Kågedal ◽  
Russ Wada ◽  
Hanbin Li ◽  
...  
Keyword(s):  
Dose Finding ◽  
Fixed Dose Combination ◽  
Fixed Dose ◽  
Phase Ib ◽  
Finding Study ◽  
Dose Combination ◽  
Dose Finding Study

scholarly journals Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer

2002 ◽  
Vol 13 (4) ◽  
pp. 546-552 ◽  
Author(s):  
M. Venturini ◽  
L. Del Mastro ◽  
O. Garrone ◽  
C. Angiolini ◽  
M. Merlano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase I ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Dose Finding ◽  
First Line ◽  
Finding Study ◽  
Dose Finding Study ◽  
Line Chemotherapy

High-Dose Epirubicin + Cyclophosphamide (HD-EC) in Metastatic Breast Cancer: A Dose-Finding Study

1988 ◽  
Vol 11 (6) ◽  
pp. 287-288 ◽  
Author(s):  
G.A. Nagel ◽  
J.-H. Beyer ◽  
W. Holtkamp ◽  
D. Emrich ◽  
M. Kneba ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Metastatic Breast ◽  
Dose Finding ◽  
High Dose ◽  
Finding Study ◽  
Dose Finding Study
Sign in / Sign up

Export Citation Format

Share Document